The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
This study examines the relationship between having achieved cross-sectional remission and the need for future psychiatric and nursing home care. The study is a prospective long-term follow-up of patients with schizophrenia. Cross-sectional remission was defined by applying the Positive and Negative Syndrome Scale (PANSS) criteria requiring that none of the eight core positive and negative symptom items are scored greater than mild. Patients are followed-up by yearly clinical examinations and medical record review. Information on consumption of healthcare resources and residency status were also gathered. Visits to mental health professionals, number and duration of inpatient psychiatric or nursing home admissions were also recorded. The patients are enrolled in a 12 year prospective study, the Clinical Long-term Investigation of Psychosis in Sweden (the CLIPS study). This report covers the first seven years. Those patients who achieved cross-sectional remission at baseline had a lower total consumption of healthcare services than those who were not in remission. The latter group displayed higher values for all measured variables. Our results show that cross-sectional remission is likely to be an important goal to achieve in order to reduce future treatment needs. Patients in remission live a more independent life and have better preconditions for functioning in society.